AMERISAFE (NASDAQ:AMSF) Downgraded by Wall Street Zen to “Sell”

Wall Street Zen downgraded shares of AMERISAFE (NASDAQ:AMSF – Free Report) from a hold rating to a sell rating in a research report sent to investors on Tuesday,Wall Street Zen reports.

A number of other analysts have also recently commented on AMSF. Truist Financial dropped their price objective on AMERISAFE from $32.00 to $27.00 and set a “hold” rating for the company in a research report on Tuesday, October 13th. Citigroup reissued a “market outperform” rating on shares of AMERISAFE in a research note on Monday, October 12th. Morgan Stanley set a $40.00 target price on shares of AMERISAFE in a report on Monday, October 12th. Weiss Ratings lowered shares of AMERISAFE from a “hold (c-)” rating to a “sell (d+)” rating in a report on Tuesday, July 28th. Finally, Citizens Jmp decreased their price target on shares of AMERISAFE from $42.00 to $40.00 and set a “market outperform” rating on the stock in a research note on Monday, October 12th. Two analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company currently has an average rating of “Hold” and an average price target of $35.67.

Read Our Latest Stock Analysis on AMERISAFE

AMERISAFE Stock Performance

AMERISAFE stock opened at $25.35 on Tuesday. The stock has a fifty day moving average of $25.18 and a two-hundred day moving average of $29.47. The company has a market capitalization of $469.99 million, a price-to-earnings ratio of 12.67 and a beta of 0.24. AMERISAFE has a fifty-two week low of $23.20 and a fifty-two week high of $42.21.

AMERISAFE (NASDAQ:AMSF – Get Free Report) last released its quarterly earnings results on Tuesday, July 21st. The insurance provider reported $0.44 earnings per share for the quarter, missing analysts’ consensus estimates of $0.52 by ($0.08). AMERISAFE had a return on equity of 14.87% and a net margin of 14.00%. The company had revenue of $91.97 million during the quarter, compared to analyst estimates of $85.09 million. On average, analysts forecast that AMERISAFE will post 1.95 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the business. Counterpoint Mutual Funds LLC acquired a new position in AMERISAFE in the third quarter valued at $431,000. Versant Capital Management Inc boosted its stake in AMERISAFE by 978.4% in the 3rd quarter. Versant Capital Management Inc now owns 1,650 shares of the insurance provider’s stock worth $39,000 after buying an additional 1,497 shares during the last quarter. Sequoia Financial Advisors LLC acquired a new stake in AMERISAFE in the 2nd quarter worth about $411,000. Integrated Wealth Concepts LLC acquired a new stake in AMERISAFE in the 2nd quarter worth about $50,000. Finally, Squarepoint Ops LLC boosted its stake in AMERISAFE by 56.2% in the 2nd quarter. Squarepoint Ops LLC now owns 27,654 shares of the insurance provider’s stock worth $936,000 after buying an additional 9,949 shares during the last quarter. 97.41% of the stock is currently owned by institutional investors and hedge funds.

AMERISAFE Company Profile

(Get Free Report)

AMERISAFE, Inc (NASDAQ: AMSF) is a specialty workers’ compensation insurance company serving small and midsize employers in industries with elevated workplace risks. The company provides coverage designed to help businesses manage the costs associated with work-related injuries and occupational illnesses.

Its primary markets include construction, trucking, logging, agriculture, maritime operations, oil and gas, and other hazardous industries. In addition to insurance coverage, AMERISAFE emphasizes workplace safety, risk management, claims handling and return-to-work support to help policyholders reduce accidents and manage employee injuries.

Headquartered in DeRidder, Louisiana, AMERISAFE has historically focused on selected U.S.

Featured Articles

Analyst Recommendations for AMERISAFE (NASDAQ:AMSF)

Receive News & Ratings for AMERISAFE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMERISAFE and related companies with MarketBeat.com's FREE daily email newsletter.